WOLVERINE TRADING, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$271
-25.8%
12,000
-7.7%
0.00%
-100.0%
Q4 2022$365
-99.9%
13,000
-36.9%
0.00%0.0%
Q3 2022$589,000
+135.6%
20,600
+281.5%
0.00%
Q3 2021$250,000
-66.1%
5,400
-64.0%
0.00%
-100.0%
Q1 2021$738,000
-54.3%
15,000
-58.6%
0.00%0.0%
Q4 2020$1,614,000
+472.3%
36,245
+342.0%
0.00%
+100.0%
Q3 2020$282,000
-74.4%
8,200
-60.6%
0.00%
-66.7%
Q2 2020$1,102,000
-21.8%
20,800
-47.8%
0.00%
-25.0%
Q1 2020$1,410,000
+6.8%
39,813
+4.0%
0.00%0.0%
Q3 2019$1,320,000
-21.6%
38,300
+13.5%
0.00%
-20.0%
Q2 2019$1,683,000
-50.4%
33,737
-32.9%
0.01%
-50.0%
Q1 2019$3,392,000
+118.8%
50,300
+47.1%
0.01%
+150.0%
Q4 2018$1,550,000
+2.4%
34,200
+18.4%
0.00%
-33.3%
Q2 2017$1,514,000
+8.2%
28,885
+18.4%
0.01%
-25.0%
Q1 2017$1,399,000
+235.5%
24,400
+144.0%
0.01%
+300.0%
Q4 2016$417,00010,0000.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders